Volume Alert - GG 18.55 Goldcorp Inc $GG Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - GG 18.55 Goldcorp Inc $GG Hit a high today of 18.87 Closing the day 11/06/14 at 18.55 +0.72 +4.04% With a day low of 17.98 and a total volume of 11,451,618.

GG Recent Posts: http://investorshangout.com/Goldcorp-Inc-GG-51128/

GG Goldcorp Inc Recent Headline News

Which Gold Stocks Are Just Too Cheap to Ignore?
at The Street - Wed Nov 05, 5:05AM CST
Investors should be panning for gold mining stocks that have declined more than Comex gold. Here's the technical analysis.
ABX: 11.34 (+0.37), NEM: 18.20 (+0.37), AUY: 3.54 (+0.07), GG: 18.55 (+0.72)

Quarterly Results, Public Offering Price, and Merger Transactions Update - Research Reports on MPC, Western Gas, Goldcorp, KMI and U.S. Silica
PR Newswire - Tue Nov 04, 8:20AM CST
Today, Analysts Review released its research reports regarding Marathon Petroleum Corporation (NYSE: MPC), Western Gas Partners LP (NYSE: WES), Goldcorp Inc. (NYSE: GG), Kinder Morgan, Inc. (NYSE: KMI) and U.S. Silica Holdings, Inc. (NYSE: SLCA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7686-100free.
KMI: 38.53 (+0.43), MPC: 93.13 (+2.42), WES: 68.85 (-0.06), SLCA: 41.79 (+0.89), GG: 18.55 (+0.72)

A Morbid Halloween for 3 Gold Mining Stocks - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 1:53PM CST
We highlight three gold-mining stocks that have delivered disappointing earnings results and negative earnings surprise this earnings season.
NGD: 3.46 (+0.06), AUY: 3.54 (+0.07), GG: 18.55 (+0.72)

Are Things Only Going To Get Worse For Gold Miners?
at The Street - Mon Nov 03, 1:22PM CST
Gold miners have had a terrible year. As a barometer of sector health, the Market Vectors Gold Miners ETF (NYSEARCA:GDX) has declined 18.6% year to date, excluding dividend and over the past five yea...
ABX: 11.34 (+0.37), GLD: 109.88 (+0.09), NEM: 18.20 (+0.37), GDX: 17.21 (+0.62), GG: 18.55 (+0.72)

Shares of GG Down 32.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Nov 03, 11:00AM CST
SmarTrend identified a Downtrend for Goldcorp (NYSE:GG) on August 25th, 2014 at $26.96. In approximately 2 months, Goldcorp has returned 31.97% as of today's recent price of $18.34.
GG: 18.55 (+0.72)

Goldcorp (GG) Misses Earnings, Revenue Estimates in Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 9:35AM CST
Goldcorp Inc.'s (GG) third-quarter 2014 adjusted earnings (excluding one-time items) decreased 63.2% to $70 million or 9 cents per share from $190 million or 23 cents a share earned in the year-ago quarter.
ABX: 11.34 (+0.37), KGC: 2.21 (+0.21), NEM: 18.20 (+0.37), GG: 18.55 (+0.72)

Goldcorp (GG) Stock Hits One-Year Low on Lower Gold Prices, Weak Earnings
at The Street - Fri Oct 31, 10:24AM CDT
Shares of Goldcorp (GG) hit a 52-week low in morning trading Friday as gold prices hit a four-year low.
GG: 18.55 (+0.72)

Goldcorp (GG) Stock Lower Today After Third Quarter Earnings Results
at The Street - Thu Oct 30, 2:58PM CDT
Shares of Goldcorp (GG) fell after the company reported lower-than-expected adjusted earnings on Thursday as production missed expectations.
GG: 18.55 (+0.72)

Goldcorp Announces Third Quarter Operating and Financial Results
PR Newswire - Thu Oct 30, 7:00AM CDT
TSX: G NYSE: GG
G.TO: 21.21 (+0.89), GG: 18.55 (+0.72)

Watch for Goldcorp to Potentially Rebound After Falling 4.19% Yesterday
Comtex SmarTrend(R) - Wed Oct 29, 4:27PM CDT
Goldcorp (NYSE:GG) traded in a range yesterday that spanned from a low of $21.42 to a high of $22.33. Yesterday, the shares fell 4.2%, which took the trading range below the 3-day low of $21.91 on volume of 7.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GG: 18.55 (+0.72)

Shares of GG Down 18.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 27, 9:55AM CDT
SmarTrend identified a Downtrend for Goldcorp (NYSE:GG) on August 25th, 2014 at $26.96. In approximately 2 months, Goldcorp has returned 18.10% as of today's recent price of $22.08.
GG: 18.55 (+0.72)

West Red Lake Gold Exploration Plan for Fall 2014
Filing Services Canada XHTML - Fri Oct 24, 2:47PM CDT

GG: 18.55 (+0.72)

Goldcorp Set to Possibly Rebound After Yesterday's Selloff of 4.03%
Comtex SmarTrend(R) - Wed Oct 22, 4:19PM CDT
Goldcorp (NYSE:GG) traded in a range yesterday that spanned from a low of $22.28 to a high of $23.03. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $22.92 on volume of 7.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GG: 18.55 (+0.72)

SmarTrend Watching for Potential Rebound in Shares of Goldcorp After 4.03% Loss
Comtex SmarTrend(R) - Wed Oct 22, 4:18PM CDT
Goldcorp (NYSE:GG) traded in a range yesterday that spanned from a low of $22.28 to a high of $23.03. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $22.92 on volume of 7.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GG: 18.55 (+0.72)

Goldcorp Has Returned 14.5% Since SmarTrend Recommendation (GG)
Comtex SmarTrend(R) - Mon Oct 20, 9:28AM CDT
SmarTrend identified a Downtrend for Goldcorp (NYSE:GG) on August 25th, 2014 at $26.96. In approximately 2 months, Goldcorp has returned 14.47% as of today's recent price of $23.06.
GG: 18.55 (+0.72)

2 Gold Stocks with the Midas Touch this Earnings Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 12:22PM CDT
Gold has regained its shine as investors flocked to the safe haven metal amid gloomy economic data.
ANV: 0.86 (unch), GG: 18.55 (+0.72)

Callinex Announces Establishment of Advisory Board
CNW Group - Wed Oct 15, 7:00AM CDT
Callinex Mines Inc. (the "Company" or "Callinex" (TSX-V: CNX; OTCQX: CLLXF) is pleased to announce the establishment of an accomplished Advisory Board to provide the Company's management team with strategic guidance. The members of the Advisory Board are Mr. Carlo Civelli, Chairman, together with Messrs. Jayant Bhandari, Jason Dunning, and Stephen Swatton as board members.
BTG: 1.52 (+0.06), PRE.TO: 15.00 (-1.50), GG: 18.55 (+0.72), CNX.VN: 0.205 (unch)

Goldcorp Inc. (GG) Stock Research Links

GG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 20

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading